key: cord-0714987-x1jkxaci
authors: Poccia, Fabrizio; Agrati, Chiara; Martini, Federico; Capobianchi, Maria Rosaria; Wallace, Marianne; Malkovsky, Miroslav
title: Antiviral reactivities of γδ T cells
date: 2005-02-03
journal: Microbes Infect
DOI: 10.1016/j.micinf.2004.12.009
sha: 4cdea155c61583c70e149a95f460306eed5ed923
doc_id: 714987
cord_uid: x1jkxaci

The complex antiviral immune mechanisms involve both adaptive and innate reactions mediated by γδ T lymphocytes, whose unique immunosurveillance contributions are analyzed here in different clinical and experimental settings. It is beyond any doubt that the fast, potent, cytotoxic as well as non-cytolytic antiviral activities of γδ T cells are critical in protecting the host against diverse viral pathogens.

Murine cd T cells are the first lineage of T lymphocytes that appear in the mouse thymus, and later, predominate in epithelia. Intestinal, lymphoid and dendritic epidermal cd T cells develop normally in both athymic and MHC class I/IIdeficient mice. The expression of distinct V-gene segments not only marks different subsets, but is often associated with a more-or-less specific preponderance -for example, Vc3Vd1 in the epidermis, Vc2Vd5/6 in the lungs, Vc4Vd1 in the tongue and uterus/vagina, and Vc5Vd4/2/5/6 or Vc1Vd5/6 in the intestinal epithelium (reviewed in [1] ). Circulating murine cd T cells mainly express the Vc1Vd5/6 or Vc2Vd5 T-cell receptor (TCR) chains. Structures recognized by murine cd T cells include I-E k (Vc2Vd5), heat-shock protein 65 (HSP65) (Vc1Vd4/6), T10/22 (Vc2Vd5), HSV-gI (Vc2Vd8) and stressed epithelial cells (Vc3Vd1). However, cd T-cell stimulatory activities of murine cd ligands have not been examined in vivo, and there is no rodent model for assessing the therapeutic potential of activated cd T cells, with the exception of human cd T-cell testing in SCID mice [2] .

Similarly to the mouse, the expression of human cd TCR variable segments is associated with tissue prevalence-for instance, the Vd1 T-cell subset appears to have largely resident characteristics, whereas Vc9Vd2 T lymphocytes fre-quent the adult peripheral blood. Human Vd1 T cells form a large subpopulation of gut, skin and lung lymphocytes. Some Vd1 T cells seem to recognize CD1c through the TCR and/or MIC-A/B stress-molecules through the NKG2D receptor [3] . In contrast, human Vc9Vd2 T cells are the main blood/lymphoid organ cd T-cell subpopulation and typically recognize phosphomonoester molecules synthesized in the mevalonate and DOXP metabolic pathways [4] . Since cd T cells display potent antiviral activities against many different viruses, it may be possible to design novel antiviral therapies utilizing activated cd T cells.

The involvement of cd T cells in antiviral immunosurveillance has been extensively analyzed (Table 1) . A large number of studies indicate that cd T cells participate in immune responses against the human immunodeficiency virus (HIV) (reviewed in [5] ) and other retrovirus such as the human T-cell leukemia virus (HTLV) type 1 [6, 7] , the simian immunodeficiency virus (SIV) [8] and the murine leukemia virus (MuLV) [9, 10] . An extrathymic expansion of a TCR-d clonotype among Vd5 T cells was found to correlate with the presence of an endogenous MuLV in inbred mice [10] . A genotype-independent extrathymic expansion of a cd T-cell subset (Vc9Vd2) has also been reported in human and nonhuman primates [11, 12] . Upon SIV infection of rhesus monkeys (Macaca mulatta), transient increases in the percentage of Vc9Vd2 T cells were observed [13] . cd T cells from SIVinfected macaques appear to express more activation markers, such as CD69, CD44 and the memory marker CD45RO, differently from uninfected animals. The simian cd T cells were also able to suppress SIV replication in vitro, assessed by p27 antigenemia [8] . Significant increases in cd T cells eluted from the rectal mucosa were observed in 'protected' versus SIV-infected macaques [14] . After vaccination with attenuated SIV, the protection against pathogenic virus at the mucosal challenge site was accompanied by an expansion of cd T cells concomitantly with dendritic cells [15] . Investigations of the mechanism of protection have revealed that simian cd T cells can generate antiviral factors RANTES, MIP-1a and MIP-1b, which prevent SIV infection by competing for the CCR5 co-receptors. Similarly, in Homo sapiens, several studies suggest a potent antiviral activity of Vc9Vd2 T cells against HIV. Human Vc9Vd2 T cells exert both cytolytic [16, 17] and non-cytolytic (through the induction of b-chemokines such as MIP-1a/b and RANTES) antiviral activity. The efficacy of inhibition is comparable to that of CD8+ T lymphocytes [17, [18] [19] [20] . Moreover, human Vc9Vd2 T cells have been shown to release a-defensin [21] and other, yet unidentified, non-cytolytic antiviral factors [22] .

Increases in relative and absolute numbers of cd T cells have been described in the peripheral blood of HIV-1-seropositive persons, including those free of opportunistic pathogens [23] [24] [25] . These increases are due to the Vd1 T-cell subset, resulting in an inversion of the adult peripheral blood Vd2 to Vd1 ratio (>2 in HIV-seronegative controls) [25, 26] . Augmented representation of the Vd1 T-cell subset in the peripheral blood of HIV-seropositive persons is independent of particular c-chain expression, not correlated with a CDR3dependent Vd1 selection [26] , not associated with any particular junctional motifs [26] , and not correlated with high levels of HIV-1 antigenemia [25] . Moreover, the comparison between mucosal and blood cd T cells revealed a similar increase in Vd1 T cells [27] . In both compartments, antiretroviral treatments were not able to restore Vd1 T cells to normal levels [27, 28] , indicating that factors other than HIV replication are responsible for the Vd1 T-cell expansion. An increased expression of 'natural killer receptors' was found on Vd1 T cells from HIV patients [29] . This may be due to chronic activation of Vd1 T cells in HIV-1-infected persons. These cells are able to lyse uninfected bystander CD4+ T cells during HIV infection [30] , indicating that the Vd1 Tcell subset may directly contribute to the HIV-associated immunopathogenesis.

The HIV-associated Vd1 T-cell increase is accompanied by a polyclonal Vc9Vd2 T-cell decrease, in both the peripheral blood and the mucosal tissues. This situation is even more [26, 27, 31, 32] . The low numbers of Vc9Vd2 T cells remaining after HIV infections are frequently anergic [32] . Although influencing the cytokine production of normal Vc9Vd2 T cells, neither interleukin-12 (IL-12) nor IL-15 were able to reverse the Vd2 T-cell anergy observed in HIVinfected patients [33] . Although the spectrotype analysis of Vd2 and Vd1 did not reveal significant differences in HIV+ individuals compared to uninfected controls [26, 32] , significant changes have been observed in the Vc9 (Vc2 in an alternate nomenclature) chain repertoire. Among all possible combinations of Vc9 with any of the four known Jc segments, healthy adults preferentially express the Vc9 and JcP chain combination [34, 35] . This pairing is also associated with the strongest responses to nonpeptidic antigens (NpAgs), even though the response is still polyclonal [36] . Typically, Vc9Vd2 T cells stimulated with NpAgs mainly exhibit JcP rearrangements (alternatively known as Jc1.2) [36] . Also, gene transfer studies have shown that the Vc9-JcP combination is associated with the strong NpAg responsiveness, whereas Vc9Vd2 TCRs containing the other Vc9-Jc combinations appear to be somewhat less responsive. The lysine residues within the JcP segment are unique and absent in other human Jc segments. Mutations of these lysine residues completely abrogated the responsiveness to NpAgs without affecting the response to anti-CD3 monoclonal antibodies (mAb) [37] . This suggests that the positively charged lysine residues in the TCRc CDR3 region encoded by the germline JcP segment play a key role in the response to NpAgs. HIV-infected individuals have substantially reduced numbers of Vc9 cells with the Vc9-JcP rearrangement [38] . This alteration and the reduced T-cell reactivities were shown to be partially reversed towards 'normal levels' during highly active antiretroviral therapy (HAART) treatment [31, 39] . The depletion of Vc9Vd2 T cells is the earliest known TCR-specific cell deletion associated with HIV infection. Importantly, the loss of Vc9Vd2 T cells may be a contributing factor in the establishment of viral persistence in AIDS by reducing the level of type 1 cytokines [38] . In HIV-infected persons undergoing structured treatment interruption (STI) [40] , a loss in circulating Vc9Vd2 T cells has been observed, suggesting that acute HIV replication may influence Vc9Vd2 homeostasis. Specifically, the reduction in cd T-cell numbers was evident in the effector CD45RA-CD27-Vc9Vd2 T-cell subset. In addition, NpAg-driven interferon-c (IFN-c) production was substantially decreased during the STI. After HAART resumption and the ensuing inhibition of HIV replication, the Vc9Vd2 T-cell reactivities were restored. Altogether, these observations indicate that Vc9Vd2 T cells are activated soon after the initiation of active HIV replication, but are rapidly lost in HIV-infected persons who fail to control viremia. In this context, it is noteworthy that the Vc9Vd2 T-cell loss observed after the STI-induced increase in plasma HIV-RNA could mimic the status found in the very early phases of HIV infection. In summary, these data indicate that soon after plasma HIV-RNA rebound, the Vc9Vd2 T-cell subset be-comes rapidly anergic and subsequently depleted. The mechanism of this loss may involve activation-induced cell death of reactive clones triggered by Fas/FasL interactions [41] or by NpAgs [42] . Thus, the antiviral potential of Vc9Vd2 T cells is rapidly diminished by HIV replication. Furthermore, the increase in the Vd1 subset may not result from a clonal expansion in response to HIV-rather it may be a bystander effect induced by cytokine changes occurring during the HIV disease progression. In addition, HIV-related molecules may interfere with cd T-cell homeostasis, since HIV-1 Tat seems to compete for chemokine binding to CXCR3 and CXCR4 receptors expressed on cd T cells [43] .

Expansion and activations of cd T-cell subsets were observed in hepatitis C virus (HCV) patients [44] [45] [46] [47] [48] and in other flavivirus infections such as GB virus C [49] and West Nile virus (WNV) [50] . Intrahepatic T lymphocytes from patients with chronic hepatitis C with a high histology activity index score in the liver carried mostly cd TCR [51] . Liver cd T-cell lines from HCV-infected individuals exhibit high levels of MHC-unrestricted cytotoxic activity against different targets, including primary hepatocytes, and produce IFN-c, tumor necrosis factor-a (TNF-a) and IL-8 following activation by anti-CD3. These liver cd T-cell lines do not recognize any of the structural or nonstructural proteins of HCV and have no cytotoxic activity against cells infected with recombinant vaccinia viruses expressing different HCV proteins. However, the cross-linking of CD81 (which binds HCV particles and E2) results in significant IFN-c and TNF-a production by liver cd T cells. Moreover, the Vd1 T-cell subset is polyclonally activated and recruited in the liver of chronic HCV-infected patients [52] . During chronic HCV infection, this T-cell subset may release Th1 cytokines and thus contribute to the inflammatory and necrotic processes in the liver. HIV/HCV co-infected patients show an increased frequency of both peripheral and intrahepatic Vd1 natural T lymphocytes. This may result in a higher degree of hepatic inflammation in comparison with patients with other liver diseases [28] . Altogether, these findings suggest that Vd1 T cells may play a role in the HCV-associated liver pathology [46] . In contrast, the Vc9Vd2 T-cell decrease may contribute to the impaired cellular immune response and the persistent nature of HCV disease [48] . In chronic HCV infection, similarly to the HIV infection, a Vd2/Vd1 T-cell impairment (e.g. intrahepatic Vd1 T cells are expanded in the course of disease) is also observed. The Vd2 T-cell deficit may be associated with persistent viral infections in humans [53] .

Infections with GB virus-type C (GBV-C), which is genetically similar to HCV, are relatively common worldwide. There is no convincing evidence that GBV-C infection causes any human pathology. Nevertheless, the current interest in GBV-C has been fuelled by reports indicating that HIV-infected patients co-infected with GBV-C have a slower disease pro-gression. A recent study among HIV-infected mothers from South Africa shows that mothers co-infected with GBV-C have a higher percentage of circulating cd T cells than HIVinfected mothers without GBV-C infection [49, 54] . However, in our cohort of HIV-infected patients, we have found no correlation between Vd2 T-cell exhaustion/Vd1 T-cell increase and GBV-C co-infection (Martini et al., Clin. Infect. Dis. 40 (2005) 326-328). Perhaps future studies that investigate the association between circulating cd T-cell frequencies and GBV-C load in particular clinical settings may elucidate whether or not the cd T-cell increases are directly related to GBV-C infection.

West Nile virus (WNV) is a flavivirus transmitted by mosquitoes (it recently emerged in the New York City metropolitan area and then spread to central parts of the US), with clinical manifestations ranging from asymptomatic seroconversion to fatal meningoencephalitis. WNV also causes fatal meningoencephalitis in laboratory mice. Using this model, it has been shown that mice deficient in T cells are more susceptible to WNV infection. TCRd-/-mice have elevated viral loads and a greater viral dissemination in the central nervous system [50] . Adoptive transfer of cd T cells to TCRd-/-mice reduced the susceptibility of these mice to WNV, and this effect was primarily due to IFN-c-producing T cells. These data demonstrate a distinct antiviral role of cd T cells in the control of WNV infection.

Mouse cd T cells are activated and home to the site of viral replication during paramyxo-and orthomyxovirus infections [55] [56] [57] . In the mouse model, the epithelial T-cell response to respiratory syncytial virus (RSV) infection is dominated by ab T cells, with very few cd T cells being present [58] . In H. sapiens, mitogen-stimulated cd T cells from the peripheral blood of infants with acute RSV infection produce significantly less IFN-c and more IL-4 than cd T cells from infants with acute reovirus infection [55] . During convalescence, the percentage of cd T cells producing IFN-c increases in children who recovered fully, but not in children who developed post-bronchiolitic wheezing. This suggests that cytokine production by cd T cells during acute RSV infection may play a role in the development of recurrent wheeze after RSV infection. cd T cells form a minority of lung-infiltrating lymphocytes in mice infected by Sendai virus [59] , a paramyxovirus that causes nonfatal pneumonia. The Vc1/2 phenotype is prevalent throughout the course of Sendai virus infection, with a transition to the Vc4 phenotype preponderance occurring very late in the resolution of inflammation. In measles paramyxovirus infection, the expansion of human Vc9Vd2 T cells in vitro is negatively regulated by the measles virus glycoproteins [60] , and this viral immunomodulation depends on the interaction of virus glycoproteins with surface molecules present on cd T cells and monocytes.

Most of the studies on cd T-cell involvement in orthomyxovirus infections were performed in mice, since bronchoalveolar lavage (BAL) populations from influenza A virusinfected mice express high frequencies of cd TCR chain mRNA [61, 62] . After 1 week of influenza A infection, the inflammatory exudate in the lungs consisted largely of macrophages and cd T cells, with an early increase in Vc4 T cells and a late increase in Vc2/Vc1 T cells. Since increasing numbers of macrophages expressing heat-shock protein (HSP) mRNA were found, the increase in Vc2/Vc1 T cells is consistent with the possibility that at least some of these lymphocytes are responding to the HSP-positive cells during the resolution of inflammatory process [56, 63] . A cd T-cell hybridoma established from influenza virus-infected mice responded both to influenza virus-infected stimulators and to recombinant HSP60. Interestingly, an HSP60-reactive hybridoma obtained from an uninfected mouse also responded to influenza virusinfected cells, indicating that HSP60 could indeed be the target antigen [64] . The TCR variable c-gene usage in the buccal epithelium of normal mice and that of mice challenged locally with influenza virus infection are different. In the control mice, there is a restricted use of Vc genes by buccal cd T cells (consisting primarily of Vc1.2, Vc3, and Vc5). Expression of the Vc2 and Vc5 genes is diminished in influenzainfected mice, but expression of other Vc genes does not appear to be altered by the infection. A local challenge with BSA is followed by a decreased expression of Vc1.2, Vc3, and Vc5 genes, and to a lesser extent, Vc2 gene, whereas Vc4 gene expression is increased. It is possible to speculate that the immunomodulating effect of oral antigen exposure on buccal cd T cells suggests that these cells are functionally involved in the local immune response to replicating and nonreplicating antigens in oral mucosal surfaces [57] .

When the ligand-dependent lytic function was studied in mice with influenza pneumonia, cd T cells were not constitutively cytotoxic when recovered directly from the site of virus-induced damage in the respiratory tract. However, they could display cytotoxic activities when stimulated in the presence of anti-CD3 mAb and low concentrations of rIL-2 [65] . Activated cd T cells showed profound cytotoxicity against the target cells expressing HA of either the H1 or H3 subtype, in an MHC-unrestricted manner [66] .

Substantial numbers of lung cd T cells constitutively express mRNA for a variety of cytokines and are replicating vigorously [67] . Cells that express mRNA for IL-2, IL-4, and IFN-c predominate among cd T cells recovered from inflammatory exudates [65, 68] . The frequency of cytokine mRNA+ lymphocytes is much higher than the expected frequency of virus-specific cells, which may suggest their involvement in innate immune reactions [65] .

Predictably, the immunosuppressive drug cyclosporin A diminishes the resistance of mice to influenza virus infection. Mice inoculated intravenously with trehalose-6,6′dimycolate (TDM, a glycolipid component of the mycobacterial cell wall) regain resistance to influenza virus infection impaired by cyclosporin A. It is likely that the better outcome of TDM-treated mice can be due to the activation of T, and especially of cd T, lymphocytes, since this T-cell subpopulation increases markedly in the lung of TDM-treated mice [69] .

cd T cells have been studied in the immune response to other RNA viruses such as coxsackieviruses, murine coronaviruses, and vesicular stomatitis virus. A role of cd T cells has been demonstrated in coxsackievirus-induced myocarditis [70, 71] . Cells expressing the cd TCR accounted for 5-13% of lymphocytes infiltrating the hearts of coxsackievirus H3 (CVB3)-infected mice, and adoptive transfer of cd T cells produces IFN-c-induced myocarditis by apoptosis [72] . The pathogenic cd T-cell response is linked to MHC class II haplotype, since animals lacking the MHC class II IE antigen develop minimal cardiac lesions subsequent to infection, despite high concentrations of virus in the heart. The susceptibility to myocarditis correlates with a Th1 (IFN-c-positive) cell response in the spleen, whereas disease resistance is associated with the Th2 (IL-4 positive) phenotype. cd T-cell analysis indicates that distinct cell subpopulations are activated after CVB3 infection in resistant and susceptible mice. Depletion of cd T cells abrogates myocarditis susceptibility in IE+ animals and results in a Th1 versus Th2 phenotype shift [73] . It appears that cd T cells modulate T-cell responses by selectively lysing CD4+ Th2 cells. Lysis requires direct cell-tocell interaction between the cd T-cell and the CD4+ Th2 target, and is most likely mediated through Fas/FasL interaction [74] . The heart infiltrate in CVB3-infected myocarditissusceptible mice contains abundant Vc1 T cells, whereas heart-infiltrating Vc4 T cells are plentiful in myocarditisresistant mice. Interestingly, the mAb-induced depletion of Vc1 T cells potentiates myocarditis, whereas the mAbinduced depletion of Vc4 T cells leads to suppression of myocarditis. Vc4-cell transfer experiments in myocarditisresistant mice show that the Vc4 subset promotes myocarditis. Th subset analyses suggest that Vc1 T cells induce a dominant Th2-cell response, whereas Vc4 T cells bring on a dominant Th1-cell response [75] . Infection with a myocarditisinducing strain (H3) of CVB3 preferentially activates Vc4Vd4 cells, which are strongly positive for IFN-c, whereas Vc1Vd4 cells are increased in both myocarditis-inducing strain (H3)-and myocarditis-non-inducing strain (H310A1)infected animals [76] . In this model system, the CD1 molecule is required for stimulation of Vd4 cells. The activated Vd4 cells initiate myocarditis through a IFN-c-mediated induction of Th1 cells that in turn activate autoimmune CD8+ ab T effector response. The activated Vd4 cells can adoptively transfer myocarditis to animals infected with a nonmyocarditic variant, but not to either uninfected or CD1(-/-) recipients. This demonstrates that the Vd4 myocarditic function requires both infection and CD1 expression. In contrast, CD8+ ab T cells transfer myocarditis into either infected CD1(-/-) or uninfected recipients, showing that the function of these activated CD8 effectors is both virus-and CD1independent. Thus, Vd4 cells influence CVB3 pathogenicity by their ability to manipulate both the CD4 and CD8 adaptive immune response [77] .

In a murine model of coronavirus infection induced by mouse hepatitis virus (MHV), cd T cells are the major T-cell effectors found predominantly in areas of virus antigen [78] . Infection of mice with MHV results in acute and chronic demyelination, with many similarities to multiple sclerosis in H. sapiens. Also, the fact that this pathological process is mediated by cd T cells is compatible with possible involvement of cd T cells in the pathogenesis of multiple sclerosis [79] . In MHV-infected mice, cd T cells may function by both lysing infected target cells and secreting proinflammatory cytokines. This is likely to contribute to the activation of macrophages/microglial cells that are the final effectors in the disease process.

A possible antiviral role of cd T lymphocytes may be related to their ability to promote B-cell help. Specifically, cd T cells are able to provide signals that are required for immunoglobulin isotype switching during vesicular stomatitis virus infection of immunocompetent mice [80] . The different immunoregulatory function mediated by cd T lymphocytes on CD4, CD8, B and/or DC cells may vary, depending on the viral agent and the cd T-cell subset involved in the antiviral response.

The involvement of cd T cells in natural immunity against infections caused by DNA viruses is well established ( Table 2 ). In particular, many studies describe a protective role of cd T lymphocytes in the immunosurveillance against herpesviruses in both rodents and people. In the murine model of herpes simplex virus (HSV) infection, a cd T-cell clone recognizing glycoprotein I of HSV type 1 without the requirement of expression of MHC class I or class II gene products has been isolated [81] [82] [83] . Studies of HSV disease course in TCR-cd-or TCR-ab-deficient mice have shown that cd T cells limit severe HSV-1-induced epithelial lesions and greatly reduce mortality by preventing the development of lethal viral encephalitis. This protection is due to a cd T cell-mediated arrest of both viral replication and neurovirulence [84] . After corneal HSV infection in mice, cd T lymphocytes are able to infiltrate the trigeminal ganglion. These cells produce IFN-c, suggesting a direct role of cd T cells in the control of virus replication through the production of such antiviral molecules [85] .

HSV-specific cd T cells can be isolated from infected persons and are able to express HSV-specific cytotoxic activity. To mediate the lytic activity, these virus-specific CTLs require the expression of HLA class I molecules on the surface of target cells [86] . However, the response itself appears to be HLA-unrestricted, suggesting the possible involvement of NK receptors expressed by human cd T cells [87] [88] [89] [90] . Specifi-cally, PBMC from HSV-seropositive individuals stimulated with autologous HSV-infected PHA blasts show an expansion of Vc9Vd2 T cells, and are able to lyse HSV-infected, but not mock-infected targets. Also, Vc9Vd2 T cells obtained after PHA or mycobacterial stimulation are able to lyse HSVinfected as well as unrelated vaccinia-infected targets, but not mock-infected targets [91] . Similarly to the mouse models, human cd T cell-mediated cytotoxic activity is not restricted by classical HLA class I or class II molecules, and can be blocked by mAbs to CD3 and the cd TCR. Interestingly, cd T cells have been shown to be susceptible to human herpes virus (HHV)-6 infection, and display cytolytic activities against both autologous and heterologous target cells infected with HHV-6. HHV-6 infection induces CD4 expression in cd T lymphocytes, rendering them susceptible to HIV [92] . Thus, HHV-6 has evolved strategies to interfere with cd T-cell antiviral activities, exploiting the activation of these cells to expand the pool of target cells susceptible to productive infection. Lymphocytes bearing cd TCRs are expanded during other herpesvirus infections, such as the acute phase of Epstein-Barr virus (EBV)-induced infectious mononucleosis. These cd T cells express activation antigens, such as HLA-DR and CD38, and persist during the convalescent phase of infectious mononucleosis, suggesting a possible role of cd T cells in the control of primary EBV infection [93] . A large proportion of human sinovial tissue-and peripheral bloodderived Vd1 T-cell clones can proliferate in response to stimulation with autologous and allogeneic EBV-transformed B-lymphoblastoid cell lines (LCL). This proliferative response is dependent on contact between responder and stimulator cells, and can be blocked by a mAb to LFA-1 and by antibodies to the cd TCR/CD3 complex [94] . In subsequent studies, the nature of the stimulatory ligand was found to be of cellular rather than of viral origin, and its expression was upregulated upon activation of B cells. Moreover, the expression of B7 and CD39 molecules on the surface of activated B cells appears to be crucial, since antibodies to these structures can block the induction of Vd1 T-cell proliferation. Finally, no predominant V-D-J sequences have been found among the LCL-responsive Vd1 T-cell clones, arguing strongly against a mono-or oligoclonal Vd1 T-cell response to LCL [95] .

In a murine model of cytomegalovirus (M-CMV) infection, the number of cd T cells increases in the liver and peritoneal cavity from day 3, and reaches a peak on day 5 after intraperitoneal infection. The cd T cells show an activated T-cell phenotype, largely expressed Vc1, and may recognize the HSP65. M-CMV-induced cd T cells express IFN-c and TNF-a, but not IL-4, and are able to produce IFN-c in vitro in response to HSP65. Moreover, depletion of cd T cells by anti-TCR cd mAb treatment results in a significant increase in virus titer and a parallel decrease in IFN-c in the liver on day 3 after M-CMV infection. This further supports the importance of cd T cells in early protection against infection [96] . In another study, the phenotypic and functional characteristics of leukocytes infiltrating the submaxillary gland (SMG) were analyzed in CMV-infected BALB/c mice. A robust innate immune response comprising CD11c+ MHC II+ CD11b-CD8a+ dendritic cells and cd T cells was prominent through at least 28 days post-infection. The expression of IFN-c, IL-10 and CC chemokines was extraordinarily high in the SMG in response to M-CMV infection, indicating that innate and acquired immune responses are quite vigorous in the SMG of CMV-infected mice [97] . In a rat model, the accumulation of cd T cells in regional popliteal lymph nodes (PLN) starts 2 days after inoculation of CMV into the footpad. PLN cd T cells inhibit the plaque development and the spread of CMV infection, are negative for CD4 and CD8 receptors, proliferate in response to IL-2, and contain high levels of IFN-c. The IFN-c positivity correlates with the curing of fibroblasts from virus infection [98] .

A dramatic expansion of cd T cells in the peripheral blood has been noted during post-transplant human cytomegalovirus (H-CMV) infections. This increase is associated with the activation of cd T cells expressing mainly the Vd1 or Vd3 TCR chains. Analyses of TCR junctional diversity revealed that H-CMV infection is accompanied by a selective expansion of Vd1 T cells bearing recurrent junctional amino acid motifs, suggesting an in vivo antigen-driven selection of cd T-cell subsets during the course of H-CMV infection [99] . Both Vd1 and Vd3 T cells from H-CMV-infected kidney recipients are able to proliferate in vitro in the presence of free CMV virions or CMV-infected fibroblast lysates, but not in the presence of uninfected or other herpesvirus-infected fibroblast lysates. This suggests that a population of cd T cells may play an important role in immune responses to H-CMV infections. The relationship between the evolution of CMV infection and the kinetics of cd T-cell amplification has been followed up to 10 months after transplantation. Patients with late cd T-cell expansions (≥45 days) have significantly longer (P < 0.0001) and higher (P < 0.0003) pp65 antigenemia and are more symptomatic than patients with early expansions. Moreover, single patient analyses have shown that cd T-cell expansions parallel the resolution of CMV infection, strongly supporting the idea of a protective role of cd T cells in H-CMV infections [100] .

An increase in cd T cells during hepatitis B virus (HBV) seroconversion has been described. It is conceivable that these cells may be involved in HBV immunosurveillance and maintaining low virus levels during seroconversion [101] .

The role of cd T cells in innate resistance to vaccinia virus (VV) infection has been studied using normal, aband cd-TCR-deficient mice. Mice deficient in cd T cells have significantly higher VV titers and increased mortality in comparison with normal mice. There is a rapid and profound VV-induced increase in IFN-c-producing cd T cells in the peritoneal cavity and spleen of ab-TCR-deficient VV-infected mice. This rapid response occurs in the absence of priming, and there are substantial numbers of VV-specific cd T cells present in uninfected mice. These cells express a constitutive cytolytic activity, which is increased after VV infection. VV-infected ab-deficient mice show a transient control of VV replication on the day of the cd T-cell response peak, but thereafter cd T-cell numbers decline, and the virus infection recrudesces. Thus, cd T cells can be mediators of innate immunity to viruses, having a significant impact on virus replication in the presence or absence of adaptive immune responses [102] .

In H. sapiens, the role of cd T cells has been assessed in vaccinated subjects who received live recombinant canarypox virus expressing HIV proteins or soluble MN rgp120. Canarypox virus vaccination induces increased cd T-cell responses detectable after secondary in vitro expansions. These augmented cd T-cell responses are specific for canarypox virus, but not for HIV antigens, and are mediated primarily by IFN-c-producing Vc9 T cells. cd T-cell lines generated from canarypox vaccinees respond to canarypox antigens but not to mycobacterial antigens. Increased IFN-c production by cd T cells may boost the induction of protective type 1 memory immunity and augment the effectiveness of live vaccines [103] .

Clearly, cd T cells play an important role in innate and adaptive immune responses to viral infections. The molecules rec-ognized by cd T cells during viral infections are probably of cellular rather than viral origin and appear to be metabolites of altered cellular pathways, in particular the products of the mevalonate pathway. Moreover, virus-exposed cd T cells can be rapidly activated by type I interferons (IFN-a, IFN-b) , a phenomenon that is likely to contribute to the effective antiviral response [104] . The antiviral role of cd T cells has been intensively studied in mice and correlated with the production of IFN-c by distinct cd T-cell subsets. In H. sapiens, Vd1 T cells are systemically or locally expanded in some chronic viral infections and are probably involved in the accompanying inflammatory processes. Vc9Vd2 T cells are activated early during the acute phase of most viral infections and can display potent antiviral responses. Moreover, a plethora of soluble factors with antiviral characteristics induced by Vc9Vd2-stimulatory molecules can influence the outcome of viral infections. In addition to their direct antiviral properties, many of these molecules play crucial immunoregulatory roles and are decisive in controlling the complex antiviral immunosurveillance function as well as in establishing the correct immunological memory environment in vivo.

Gammadelta T cells: functional plasticity and heterogeneity

Antibacterial effect of human Vgamma2Vdelta2 T cells in vivo

A genetic basis for human gammadelta T-cell reactivity towards microbial pathogens

Conventional and non-conventional recognition of non-peptide antigens by T lymphocytes

Innate T-cell immunity in HIV infection: the role of Vgamma9Vdelta2 T lymphocytes

Increase in T cells expressing the gamma/delta receptor and CD4+CD8+ double-positive T cells in primary immunodeficiency complicated by human T-cell lymphotropic virus type I infection

Human T-cell leukemia virus type I (HTLV-I) infection of T cells bearing T-cell receptor gamma delta: effects of HTLV-I infection on cytotoxicity

Mechanisms of simian gamma delta T cell cytotoxicity against tumor and immunodeficiency virus-infected cells

Thymic targets for Abelson murine leukemia virus are early gamma/delta T lymphocytes

The presence of an endogenous murine leukemia virus sequence correlates with the peripheral expansion of gamma delta T cells bearing the BALB invariant delta (BID) T cell receptor delta

Evidence for extrathymic changes in the T cell receptor gamma/delta repertoire

Conservation of nonpeptide antigen recognition by rhesus monkey Vgamma2Vdelta2 T cells

Gamma delta T cells in rhesus monkeys and their response to simian immunodeficiency virus (SIV) infection

The role of gammadelta T cells in generating antiviral factors and beta-chemokines in protection against mucosal simian immunodeficiency virus infection

Early protection against pathogenic virus infection at a mucosal challenge site after vaccination with attenuated simian immunodeficiency virus

CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive Vgamma9Vdelta2 T lymphocytes

Gamma delta T lymphocyte responses to HIV

Activation of C-C betachemokines in human peripheral blood gammadelta T cells by isopentenyl pyrophosphate and regulation by cytokines

Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells

Vgamma9Vdelta2 T lymphocytes suppress in vitro human immunodeficiency virus type 1 replication by cell-released antiviral factors including CC chemokines

The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations

Vgamma9Vdelta2 T lymphocytes suppress in vitro human immunodeficiency virus type 1 replication by cell-released antiviral factors including CC chemokines

T cell receptor gamma/delta+ lymphocyte subsets during HIV infection

Selective increase of a subset of T cell receptor gamma delta T lymphocytes in the peripheral blood of patients with human immunodeficiency virus type 1 infection

A subset of gamma delta lymphocytes is increased during HIV-1 infection

CDR3-independent gamma delta Vdelta1+ T cell expansion in the peripheral blood of HIV-infected persons

Human immunodeficiency virus type 1 induces persistent changes in mucosal and blood gammadelta T cells despite suppressive therapy

Gammadelta T cell activation by chronic HIV infection may contribute to intrahepatic Vdelta1 compartmentalization and hepatitis C virus disease progression independent of highly active antiretroviral therapy

Differential expression of natural killer receptors on Vdelta1 gammadelta T cells in HIV-1-infected individuals

Peripheral blood cytotoxic gammadelta T lymphocytes from patients with human immunodeficiency virus type 1 infection and AIDS lyse uninfected CD4+ T cells, and their cytocidal potential correlates with viral load

Gammadelta T-cell anergy in human immunodeficiency virus-infected persons with opportunistic infections and recovery after highly active antiretroviral therapy

Peripheral Vgamma9/Vdelta2 T cell deletion and anergy to nonpeptidic mycobacterial antigens in asymptomatic HIV-1-infected persons

Regulation by cytokines (IL-12, IL-15, IL-4 and IL-10) of the Vgamma9Vdelta2 T cell response to mycobacterial phosphoantigens in responder and anergic HIV-infected persons

Molecular analysis of human gamma/delta+ clones from thymus and peripheral blood

Close correlation between Daudi and mycobacterial antigen recognition by human gammadelta T cells and expression of V9JPC1 gamma/V2DJC delta-encoded T cell receptors

In vitro stimulation with a non-peptidic alkylphosphate expands cells expressing Vgamma2-Jgamma1.2/Vdelta2 T-cell receptors

Essential contribution of germline-encoded lysine residues in Jgamma1.2 segment to the recognition of nonpeptide antigens by human gammadelta T cells

HIV-mediated gammadelta T cell depletion is specific for Vgamma2+ cells expressing the Jgamma1.2 segment

Association between longer duration of HIV-suppressive therapy and partial recovery of the V gamma 2 T cell receptor repertoire

Acute human immunodeficiency virus replication causes a rapid and persistent impairment of Vgamma9Vdelta2 T cells in chronically infected patients undergoing structured treatment interruption

Fas-dependent, activationinduced cell death of gammadelta cells

Involvement of the Fas/Fas ligand pathway in activation-induced cell death of mycobacteriareactive human gamma delta T cells: a mechanism for the loss of gammadelta T cells in patients with pulmonary tuberculosis

Migration of Vdelta1 and Vdelta2 T cells in response to CXCR3 and CXCR4 ligands in healthy donors and HIV-1-infected patients: competition by HIV-1 Tat

Lymphocyte distribution and intrahepatic compartmentalization during HCV infection: a main role for MHC-unrestricted T cells

CD4+/CD8+ ratio of liver-derived lymphocytes is related to viraemia and not to hepatitis C virus genotypes in chronic hepatitis C

Intrahepatic natural immunity and HCV immunopathogenesis

Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions

Decrease in CD3-negative-CD8dim(+) and Vdelta2/Vgamma9 TcR+ peripheral blood lymphocyte counts, low perforin expression and the impairment of natural killer cell activity is associated with chronic hepatitis C virus infection

GB virus type C coinfection in HIV-infected African mothers and their infants

IFN-gamma-producing gamma delta T cells help control murine West Nile virus infection

Liver-infiltrating CD56 positive T lymphocytes in hepatitis C virus infection

Vdelta1 T lymphocytes expressing a Th1 phenotype are the major gammadelta T cell subset infiltrating the liver of HCV-infected persons

Natural T cell immunity to intracellular pathogens and nonpeptidic immunoregulatory drugs

GB virus type C: a virus in search of a disease or a role in HIV therapy?

Respiratory syncytial virus infection suppresses IFN-gamma production of gammadelta T cells

Late dominance of the inflammatory process in murine influenza by gamma/delta+ T cells

Modulation of gamma delta T cells in mouse buccal epithelium following antigen priming

Pulmonary epithelial T cells induced by viral infection express T cell receptors alpha/beta

Extent of gamma delta T cell involvement in the pneumonia caused by Sendai virus

Expansion of human gamma/delta T cells in vitro is differentially regulated by the measles virus glycoproteins

Analyzing the distribution of cells expressing mRNA for T cell receptor gamma and delta chains in a virus-induced inflammatory process

HSP65 mRNA+ macrophages and gamma delta T cells in influenza virus-infected mice depleted of the CD4+ and CD8+ lymphocyte subsets

A role for gamma/delta T cells in the primary immune response to influenza virus

Selective response of gamma delta T-cell hybridomas to orthomyxovirus-infected cells

Activation of cytokine genes in T cells during primary and secondary murine influenza pneumonia

Role of gamma delta TCR+ lymphocytes in the augmented resistance of trehalose 6,6′-dimycolate-treated mice to influenza virus infection

Activation status of the CD4-8-gamma delta-T cells recovered from mice with influenza pneumonia

Cytokine profiles of bronchoalveolar lavage cells from mice with influenza pneumonia: consequences of CD4+ and CD8+ T cell depletion

Mechanisms of augmented resistance of cyclosporin A-treated mice to influenza virus infection by trehalose-6,6′-dimycolate

T cells expressing the gamma delta T-cell receptor potentiate coxsackievirus B3-induced myocarditis

Synergism between adriamycin and coxsackie virus group B type 3 (CVB3) in induction of myocardial injury: potential role for gamma/delta TcR+ T lymphocytes in pathogenesis

Modulation of cytokine expression by CD4+ T cells during coxsackievirus B3 infections of BALB/c mice initiated by cells expressing the gamma delta+ T-cell receptor

gamma delta+ T cells regulate major histocompatibility complex class II (IA and IE)-dependent susceptibility to coxsackievirus B3-induced autoimmune myocarditis

Apoptosis in coxsackievirus B3-induced myocarditis and dilated cardiomyopathy

V gamma 1+ T cells suppress and Vgamma4+ T cells promote susceptibility to coxsackievirus B3-induced myocarditis in mice

Cytokine production by Vgamma(+)-T-cell subsets is an important factor determining CD4(+)-Th-cell phenotype and susceptibility of BALB/c mice to coxsackievirus B3-induced myocarditis

Vgamma4(+) T cells promote autoimmune CD8(+) cytolytic T-lymphocyte activation in coxsackievirus B3-induced myocarditis in mice: role for CD4(+) Th1 cells

Virus-induced demyelination in nude mice is mediated by gamma delta T cells

Phenotypic and functional properties of gamma delta T cells from patients with Guillain Barre syndrome

Interferon gamma-producing gammadelta T cell-dependent antibody isotype switching in the absence of germinal center formation during virus infection

A murine CD4-, CD8-T cell receptorgamma delta T lymphocyte clone specific for herpes simplex virus glycoprotein I

Unique antigen recognition by a herpesvirus-specific TCR-gamma delta cell

HSV-1 glycoprotein I-reactive TCR gamma delta cells directly recognize the peptide backbone in a conformationally dependent manner

T cell receptor-gamma/delta cells protect mice from herpes simplex virus type 1-induced lethal encephalitis

Macrophage control of herpes simplex virus type 1 replication in the peripheral nervous system

HLA-unrestricted killing of HSV-1-infected mononuclear cells. Involvement of either gamma/delta+ or alpha/beta+ human cytotoxic T lymphocytes

Gammadelta T cell activation or anergy during infections: the role of nonpeptidic TCR ligands and HLA class I molecules

Innate T-cell immunity to nonpeptidic antigens

Phenotypic and cytokine analysis of human peripheral blood gamma delta T cells expressing NK cell receptors

MICA engagement by human Vgamma2Vdelta2 T cells enhances their antigen-dependent effector function

Recognition and destruction of virus-infected cells by human gamma delta CTL

Infection of gamma/delta T lymphocytes by human herpesvirus 6: transcriptional induction of CD4 and susceptibility to HIV infection

Gamma delta T cell receptor-bearing lymphocytes during Epstein-Barr virus infection

A subset of Vdelta1+ T cells proliferates in response to Epstein-Barr virus-transformed B cell lines in vitro

Functional and molecular characterization of B cellresponsive Vdelta1+ gamma delta T cells

Vgamma1+ gammadelta T cells play protective roles at an early phase of murine cytomegalovirus infection through production of interferon-gamma

Vigorous innate and virus-specific cytotoxic T-lymphocyte responses to murine cytomegalovirus in the submaxillary salivary gland

Phenotypic profile and functional characterization of rat lymph node-derived gammadelta T cells: implication in the immune response to cytomegalovirus

Implication of gammadelta T cells in the human immune response to cytomegalovirus

Cytomegalovirus infection in transplant recipients resolves when circulating gammadelta T lymphocytes expand, suggesting a protective antiviral role

Composition of peripheral blood lymphocyte populations during different stages of chronic infection with hepatitis B virus

Innate immunity to viruses: control of vaccinia virus infection by gamma delta T cells

Canarypox vaccines induce antigen-specific human gammadelta T cells capable of interferon-gamma production

Polyinosinic-polycytidylic acid-mediated stimulation of human gammadelta T cells via CD11c dendritic cell-derived type I interferons

Flow cytometric analysis of gamma delta T cells and natural killer cells in HIV-1 infection

Expression of the T-cell receptor in HIV infection

Transitory expansion of a CD3+TcR gamma/delta+CD16+ lymphocytic population in two patients with advanced human immunodeficiency virus infection and high levels of natural killer activity

T cell receptor gamma delta repertoire in HIV-1-infected individuals

Programmed cell death induced by HIV type 1 antigen stimulation is associated with a decrease in cytotoxic T lymphocyte activity in advanced HIV type 1 infection

Similarity of expression of activation markers and CD28 on gamma delta and alpha beta-receptor T cells in HIV infection

Reciprocal alterations of Th1/Th2 function in gammadelta T-cell subsets of human immunodeficiency virus-1-infected patients

Phenotypic analysis of peripheral blood gammadelta T lymphocytes and their targeting by human immunodeficiency virus type 1 in vivo

Natural T, gammadelta, and NK cells in mycobacterial, Salmonella, and human immunodeficiency virus infections

Gammadelta T cells increase with Mycobacterium avium complex infection but not with tuberculosis in AIDS patients

Analysis of the TCR Vgamma repertoire in healthy donors and HIV-1-infected individuals

Analysis of gamma delta+ T cells in peripheral blood of children with perinatal human immunodeficiency virus (HIV) infection

Vdelta1 T cells expanded in the blood throughout HIV infection display a cytotoxic activity and are primed for TNF-alpha and IFNgamma production but are not selected in lymph nodes

Gamma delta-T cellreceptor-positive lymphocytes inhibit human hematopoietic progenitor cell growth in HIV type 1-infected patients

Intraepithelial gamma/delta T cells in duodenal mucosa are related to the immune state and survival time in AIDS

Increase in Vdelta1+ gammadelta T cells in the peripheral blood and bone marrow as a selective feature of HIV-1 but not other virus infections

HLA class I-restricted recognition of an HIV-derived epitope peptide by a human T cell receptor alpha chain having a Vdelta1 variable segment

Decreased blood TcR gamma delta+ lymphocytes in AIDS and p24-antigenemic HIV-1-infected patients

Peripheral gamma delta T-cell populations in HIV-infected individuals with mycobacterial infection

Double-edged effect of Vgamma9/Vdelta2 T lymphocytes on viral expression in an in vitro model of HIV-1/mycobacteria co-infection

Bacterial antigen activation of Vdelta1 and Vdelta2 gammadelta T cells of persons infected with human immunodeficiency virus type 1

Lack of CD27-CD45RA-Vgamma9Vdelta2+ T cell effectors in immunocompromised hosts and during active pulmonary tuberculosis

Enhanced expression of activation antigens HLA-DR and CD69 on gamma delta T cells but impaired interleukin-2-induced upregulation in HIV-1 infection

Selective expansion of gammadelta T cells among liver-derived lymphocytes of AIDS patients with disseminated Mycobacterium avium complex infection

Role of gamma delta T-lymphocytes in HIV infection

Antiviral activity and anergy of gammadeltaT lymphocytes in cord blood and immuno-compromised host

Increases in CD3+CD4-CD8-T lymphocytes in AIDS patients with disseminated Mycobacterium avium-intracellulare complex infection

Functional gamma delta T-lymphocyte defect associated with human immunodeficiency virus infections

Mycobacteria-reactive gamma delta T cells in HIV-infected individuals: lack of V gamma 9 cell responsiveness is due to deficiency of antigen-specific CD4 T helper type 1 cells

Specificity and function of gamma delta T lymphocytes

Antiviral activity of primate gamma delta T lymphocytes isolated by magnetic cell sorting

Inhibition of adaptive Vgamma2Vdelta2+ T-cell responses during active mycobacterial coinfection of simian immunodeficiency virus SIVmac-infected monkeys

Characterization of liver T-cell receptor gammadelta T cells obtained from individuals chronically infected with hepatitis C virus (HCV): evidence for these T cells playing a role in the liver pathology associated with HCV infections

Involvement of gamma delta T cells in respiratory virus infections

Intracellular IFN-gamma expression in natural killer cells precedes lung CD8+ T cell recruitment during respiratory syncytial virus infection

RSV bronchiolitis, gammadelta T cells and asthma: are they linked?

T cell subset analysis in peripheral blood of children with RSV bronchiolitis, Scand

Sendai virus pneumonia: evidence for the early recruitment of gamma delta T cells during the disease course

T cells expressing the gamma delta T cell receptor induce apoptosis in cardiac myocytes

CD4+ contrasuppressor T cells improve the resistance of thermally injured mice infected with HSV

Protective immunity against herpes simplex virus generated by DNA vaccination compared to natural infection

Gammadelta T cell response induced by vaginal Herpes simplex 2 infection

This study was supported by grants from the Italian Ministry of Health, the "Istituto Superiore di Sanità" and the NIH.